Molecular Markers of Patient Outcome in Prostate Cancer Treated with Radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x

William Levin, MD
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 6 de noviembre del 2001

Translation for this article does not exist


Click on any of these terms for more related articles